Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_4
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (50.0%)
N/A2 (50.0%)

Trials by Status

completed250%
unknown125%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_4

A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease

NCT03119662
unknownnot_applicable

Adequate Hydration Therapy Combined With Intravenous Infusion of Isosorbide Dinitrate Prevention for CIN

NCT02718521
completednot_applicable

Central Venous Pressure Guided Hydration Prevention for Contrast-Induced Nephropathy

NCT02405377
completedphase_4

A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications

NCT00347022

Clinical Trials (4)

Showing 4 of 4 trials
NCT03119662Phase 4

A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease

Terminated
NCT02718521Not Applicable

Adequate Hydration Therapy Combined With Intravenous Infusion of Isosorbide Dinitrate Prevention for CIN

Unknown
NCT02405377Not Applicable

Central Venous Pressure Guided Hydration Prevention for Contrast-Induced Nephropathy

Completed
NCT00347022Phase 4

A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4